Nexpovio
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nexpovio, covering 2023-08-17 to 2026-08-05. Get the full timeline:
Most recent: EMA Authorised: Nexpovio (selinexor) — Stemline Therapeutics B.V.
3 regulatory and trial events tracked for Nexpovio, covering 2023-08-17 to 2026-08-05. Get the full timeline:
Most recent: EMA Authorised: Nexpovio (selinexor) — Stemline Therapeutics B.V.